Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Jingsong Wang

Tracked across 3 events · 19 articles · First seen Jun 10, 2026 · Last active Sep 11, 2026

Sentiment
3
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 0
Business
Impact: Jingsong Wang, as the Founder, Chairman, and CEO of Harbour BioMed, expressed satisfaction with the NMPA's acceptance of the IND application for HBM7004, highlighting the company's strategy in developing differentiated immunotherapies.
Jun 10, 2026 · 7 articles
2 10
Business
Solstice Oncology, a clinical-stage immuno-oncology company focused on neoadjuvant cancer treatment, launched with a $225 million Series A financing led by RA Capital Management, with participation from Canaan Partners, Forbion Ventures and other investors. The…
Impact: As Founder, Chairman and CEO of Harbour BioMed, Jingsong Wang commented on the launch and the continued development of porustobart.
Sep 09, 2026 · 6 articles
2 0
Business
Impact: Jingsong Wang>>>, CEO of Harbour BioMed>>>, expressed enthusiasm for Dhavalkumar Patel>>>'s appointment.
Jun 12, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Jingsong Wang live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.